These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 8066680

  • 21. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 22. Effect of donor age on outcome of living related kidney transplantation.
    Kim YL, Kim JH, Kwon TH, Cho DK, Kim YW, Chang SI, Chung SK, Chang SK.
    Transplant Proc; 1996 Jun; 28(3):1580-1. PubMed ID: 8658793
    [No Abstract] [Full Text] [Related]

  • 23. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR, Tiller DJ, Mahony JF, Miach PJ, Thomson NM, Thatcher GN, Rigby RJ, Menzies BL.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract] [Full Text] [Related]

  • 24. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G, Rosen A, Loreto-Grand B, Burke G, Siquijor A, Luque C, Esquenazi V, Miller J.
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract] [Full Text] [Related]

  • 25. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F, Hidvégi M, Járay J, Alföldy F, Gyódi E, Petrányi G.
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract] [Full Text] [Related]

  • 26. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 27. Triple versus quadruple induction immunosuppression in pancreas transplantation.
    Wadström J, Brekke B, Wramner L, Ekberg H, Tydén G.
    Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
    [No Abstract] [Full Text] [Related]

  • 28. Long-term graft survival of living-related kidneys after donor-specific transfusion.
    Otsuka M, Yuzawa K, Takada Y, Taniguchi H, Fukunaga K, Seino K, Todoroki T, Fukao K.
    Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
    [No Abstract] [Full Text] [Related]

  • 29. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
    Kaden J, May G, Müller P, Groth J, Strobelt V, Eger E, Wohlfahrt L.
    Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
    [No Abstract] [Full Text] [Related]

  • 30. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
    Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F.
    Transplant Proc; 1995 Feb; 27(1):846-9. PubMed ID: 7879202
    [No Abstract] [Full Text] [Related]

  • 31. Long-term results with elective cyclosporine withdrawal at three months after renal transplantation--appropriate for living-related transplants.
    Kahn D, Ovnat A, Pontin AR, Swanepoel CR, Cassidy MJ.
    Transplantation; 1994 Dec 27; 58(12):1410-2. PubMed ID: 7809935
    [No Abstract] [Full Text] [Related]

  • 32. Kidney transplantation in elderly patients.
    Pretagostini R, Berloco P, Poli L, Rossi M, Caricato M, Casciaro G, Cocciolo P, Colonnello M, Venettoni S, Bruzzone P, Novelli G, Alfani D, Cortesini R.
    Transplant Proc; 1996 Feb 27; 28(1):192-3. PubMed ID: 8644174
    [No Abstract] [Full Text] [Related]

  • 33. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Feb 27; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 34. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M, Demirağ A, Bilgin N, Arslan G, Büyükpamukçu N.
    Transplant Proc; 1995 Oct 27; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract] [Full Text] [Related]

  • 35. Transplantation in Singapore.
    Vathsala A, Lee WT, Li MK, Woo KT, Lim CH.
    Transplant Proc; 1995 Feb 27; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract] [Full Text] [Related]

  • 36. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM, Sánchez P, Sánchez J, García J, Orero E, Beneyto I, Cruz JM.
    Transplant Proc; 1992 Dec 27; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract] [Full Text] [Related]

  • 37. Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation.
    Sheriffdeen AH, de Abrew K, Jayasekera G, Nanayakkara S, de Mel CP, Jayasinghe S, Fernando H, Rajakanthan K, Weerasinghe A, Kuruppruarchchi L.
    Transplant Proc; 1992 Oct 27; 24(5):1818. PubMed ID: 1412862
    [No Abstract] [Full Text] [Related]

  • 38. Chimerism in survivors following allograft renal transplantation.
    Lee JM, Lee CJ, Hu CY, Hsieh RP, Hu RH, Lee PH, Luh SP, Lee YC, Chu SH.
    Transplant Proc; 1996 Jun 27; 28(3):1285-7. PubMed ID: 8658662
    [No Abstract] [Full Text] [Related]

  • 39. Impact of early acute rejection on outcome of HLA-mismatched living related donor kidney transplants.
    Sumrani N, Hong JH, Georgi B, Maursky V, Hassoun A, Markell MS, Distant DA, Sommer BG.
    Transplant Proc; 1996 Jun 27; 28(3):1451-2. PubMed ID: 8658736
    [No Abstract] [Full Text] [Related]

  • 40. Kidney transplantation from living related donors.
    Mouquet C, Benalia H, Barrou B, Ourahma S, Luciani J, Coriat P, Bitker MO.
    Transplant Proc; 1996 Oct 27; 28(5):2801. PubMed ID: 8908065
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.